Insider Transactions in Q1 2024 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2024
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Indirect |
18,681
-9.7%
|
$1,064,817
$57.18 P/Share
|
|
Mar 18
2024
|
Mark Jeffrey De Long Chief Business & Strat Officer |
SELL
Open market or private sale
|
Direct |
9,913
-15.34%
|
$555,128
$56.9 P/Share
|
|
Mar 15
2024
|
James George Chopas VP/Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
184
-0.47%
|
$10,304
$56.46 P/Share
|
|
Mar 13
2024
|
Nur Nicholson Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
11,220
-8.64%
|
$639,540
$57.72 P/Share
|
|
Mar 08
2024
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
69,107
-1.97%
|
$4,284,634
$62.64 P/Share
|
|
Mar 08
2024
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,107
+5.51%
|
$207,321
$3.67 P/Share
|
|
Mar 06
2024
|
David O. Watson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,762
+3.39%
|
$48,906
$13.85 P/Share
|
|
Mar 01
2024
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-3.06%
|
$378,000
$63.41 P/Share
|
|
Mar 01
2024
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.7%
|
$60,000
$10.03 P/Share
|
|
Mar 01
2024
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
250,000
-10.56%
|
$16,000,000
$64.01 P/Share
|
|
Mar 01
2024
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+19.14%
|
$1,000,000
$4.04 P/Share
|
|
Feb 12
2024
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
781
-0.75%
|
$52,327
$67.77 P/Share
|
|
Feb 12
2024
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,148
-1.23%
|
$76,916
$67.77 P/Share
|
|
Feb 12
2024
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,431
-1.51%
|
$95,877
$67.77 P/Share
|
|
Feb 12
2024
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,962
-1.25%
|
$265,454
$67.77 P/Share
|
|
Feb 12
2024
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,148
-0.1%
|
$76,916
$67.77 P/Share
|
|
Feb 12
2024
|
Mark Jeffrey De Long Chief Business & Strat Officer |
SELL
Open market or private sale
|
Direct |
597
-0.92%
|
$39,999
$67.77 P/Share
|
|
Jan 30
2024
|
Karen Lewis Chief People Officer |
SELL
Open market or private sale
|
Direct |
883
-1.87%
|
$57,395
$65.53 P/Share
|
|
Jan 30
2024
|
Jeffrey Eisele Chief Development Officer |
SELL
Open market or private sale
|
Direct |
971
-1.67%
|
$63,115
$65.53 P/Share
|
|
Jan 29
2024
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
906
-0.96%
|
$57,984
$64.14 P/Share
|
|
Jan 29
2024
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
906
-0.86%
|
$57,984
$64.14 P/Share
|
|
Jan 29
2024
|
Nur Nicholson Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
835
-1.22%
|
$53,440
$64.14 P/Share
|
|
Jan 29
2024
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
906
-0.95%
|
$57,984
$64.14 P/Share
|
|
Jan 29
2024
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,843
-0.89%
|
$181,952
$64.14 P/Share
|
|
Jan 29
2024
|
Karen Lewis Chief People Officer |
SELL
Open market or private sale
|
Direct |
367
-0.77%
|
$23,488
$64.14 P/Share
|
|
Jan 29
2024
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
874
-0.08%
|
$55,936
$64.14 P/Share
|
|
Jan 29
2024
|
Jeffrey Eisele Chief Development Officer |
SELL
Open market or private sale
|
Direct |
279
-0.48%
|
$17,856
$64.14 P/Share
|
|
Jan 29
2024
|
Mark Jeffrey De Long Chief Business & Strat Officer |
SELL
Open market or private sale
|
Direct |
367
-0.56%
|
$23,488
$64.14 P/Share
|
|
Jan 23
2024
|
Karen Lewis Chief People Officer |
SELL
Open market or private sale
|
Direct |
4,286
-8.25%
|
$270,018
$63.69 P/Share
|
|
Jan 23
2024
|
Jeffrey Eisele Chief Development Officer |
SELL
Open market or private sale
|
Direct |
7,378
-11.21%
|
$464,814
$63.69 P/Share
|
|
Jan 22
2024
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,431
-4.02%
|
$873,015
$65.0 P/Share
|
|
Jan 22
2024
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,413
-3.49%
|
$221,845
$65.0 P/Share
|
|
Jan 22
2024
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
4,184
-3.83%
|
$271,960
$65.0 P/Share
|
|
Jan 22
2024
|
Nur Nicholson Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,593
-3.66%
|
$168,545
$65.0 P/Share
|
|
Jan 22
2024
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,551
-3.58%
|
$230,815
$65.0 P/Share
|
|
Jan 22
2024
|
Jeffrey Eisele Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,607
-2.38%
|
$104,455
$65.0 P/Share
|
|
Jan 22
2024
|
Karen Lewis Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,738
-3.24%
|
$112,970
$65.0 P/Share
|
|
Jan 22
2024
|
James George Chopas VP/Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,061
-2.64%
|
$68,965
$65.0 P/Share
|
|
Jan 22
2024
|
Mark Jeffrey De Long Chief Business & Strat Officer |
SELL
Open market or private sale
|
Direct |
1,384
-2.07%
|
$89,960
$65.0 P/Share
|
|
Jan 22
2024
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,913
-0.35%
|
$254,345
$65.0 P/Share
|
|
Jan 17
2024
|
Jeffrey Eisele Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,207
-7.17%
|
$338,455
$65.58 P/Share
|
|
Jan 17
2024
|
Karen Lewis Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,276
-5.75%
|
$212,940
$65.58 P/Share
|
|
Jan 16
2024
|
James George Chopas VP/Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
864
-2.11%
|
$57,024
$66.81 P/Share
|
|
Jan 16
2024
|
James George Chopas VP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,312
+16.86%
|
-
|
|
Jan 16
2024
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,632
-0.15%
|
$107,712
$66.81 P/Share
|
|
Jan 16
2024
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,743
+0.6%
|
-
|
|
Jan 16
2024
|
Nur Nicholson Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
1,857
-2.55%
|
$122,562
$66.81 P/Share
|
|
Jan 16
2024
|
Nur Nicholson Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,508
+21.14%
|
-
|
|
Jan 16
2024
|
Mark Jeffrey De Long Chief Business & Strat Officer |
SELL
Open market or private sale
|
Direct |
1,631
-2.38%
|
$107,646
$66.81 P/Share
|
|
Jan 16
2024
|
Mark Jeffrey De Long Chief Business & Strat Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,963
+19.83%
|
-
|